Drug Confirmation Test

Drug Confirmation Testing

Are you looking for a drug confirmation testing service near you? Look no further than Ulta Lab Tests. We provide confidential and accurate drug testing services to individuals, businesses, and government organizations.

Drug Confirmation Testing is a crucial part of the drug-testing process. Drug confirmation testing helps to accurately identify and measure the presence of certain drugs in an individual's system. Drug confirmation tests are considered the second step in a two-step clinical process to detect drugs in a person's system. Drug confirmation tests use an advanced lab analysis to confirm that drugs have been ingested, with accuracy rates ranging from 80-100%. Drug Confirmation Testing allows organizations to make well-informed decisions on how to handle any positive results obtained from a drug screening test. It plays an important role in ensuring the safety and security of workers, customers, sports participants, and society at large.


Name Matches

Drug Monitoring, Panel 1, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 1, with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes

  • If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH. 
  •  
  • If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d. 
  • .
  • Initial screen of Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing. 
  • If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class). 
  • Confirmation includes the following analytes within their associated drug class: 
  • Amphetamines: Amphetamine, Methamphetamine 
  • Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital 
  • Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam 
  • Marijuana Metabolite: Marijuana Metabolite 
  • Cocaine Metabolite: Benzoylecgonine 
  • Methadone Metabolite: EDDP, Methadone 
  • Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone 
  • Oxycodone: Noroxycodone, Oxycodone, Oxymorphone 
  • Phencyclidine: Phencyclidine

Reference Range(s)
See Laboratory Report

Alternative Name(s)
Prescription Drug Monitoring, Pain Management

Drug Monitoring, Panel 6 with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 6 with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of 6-Acetylmorphine, Alcohol Metabolites, Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).


Confirmation includes the following analytes within their associated drug class:

  • 6-Acetylmorphine: 6-Acetylmorphine
  • Alcohol Metabolites: Ethyl Glucuronide (ETG), Ethyl Sulfate (ETS)
  • Amphetamines: Amphetamine, Methamphetamine
  • Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
  • Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
  • Marijuana Metabolite: Marijuana Metabolite
  • Cocaine Metabolite: Benzoylecgonine
  • Methadone Metabolite: EDDP, Methadone
  • Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
  • Oxycodone: Noroxycodone, Oxycodone, Oxymorphone
  • Phencyclidine: Phencyclidine

Methodology
Screen: Immunoassay (IA) • Confirmation: Mass Spectrometry (MS)

Reference Range(s)
See Laboratory Report

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Alcohol Metabolite, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Alcohol Metabolite, with Confirmation, Urine - Ethyl glucuronide and ethyl sulfate are metabolites of ethanol (alcohol) that may be present in urine after ingestion of, or exposure to, drinks, foods, medication or other products containing ethyl alcohol. Incidental exposure to alcohol-containing products such as mouthwash or hand sanitizer have also been shown to produce positive alcohol metabolites test results. LC-MS/MS testing detects EtG and EtS regardless of the source. Therefore, we encourage you to interpret alcohol metabolite test results in light of the clinical picture.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Alcohol Metabolites drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80321 HCPCS: G0480).
Confirmation includes the following analytes: Ethyl Glucuronide (ETG), Ethyl Sulfate (ETS)

Reference Range(s)
Alcohol Metabolites    <500 ng/mL
  Ethyl Glucuronide (EtG)    <500 ng/mL
  Ethyl Sulfate (EtS)    <100 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Amphetamines, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Amphetamines, with Confirmation, Urine - The amphetamine class of drugs are traditionally classified as stimulants. Some members of the class (amphetamine) are prescribed for treatment of attention-deficit hyperactivity disorder (ADHD), to suppress appetite, and for narcolepsy. Other members of the class are considered drugs of abuse (methamphetamine, MDMA) with no accepted medical uses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring of the amphetamines and their metabolites is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Amphetamines drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80324; HCPCS: G0480).
Confirmation includes the following analytes: Amphetamine, Methamphetamine

Reference Range(s)
Amphetamines    <500 ng/mL
  Amphetamine    <250 ng/mL
  Methamphetamine    <250 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Barbiturates, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Barbiturates, with Confirmation, Urine - The barbiturate class of drugs are traditionally classified as sedatives and central nervous system depressants. Their principle uses are to calm the patient, produce drowsiness, and/or promote sleep. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring of the barbiturates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Barbiturates drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80345; HCPCS: G0480).
Confirmation includes the following analytes: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital

Reference Range(s)
Barbiturates    <300 ng/mL
  Amobarbital    <100 ng/mL
  Butalbital    <100 ng/mL
  Pentobarbital    <100 ng/mL
  Phenobarbital    <100 ng/mL
  Secobarbital    <100 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Base Panel, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Base Panel, with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Benzodiazepines, Cocaine Metabolite, Opiates, and Oxycodone drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Cocaine Metabolite: Benzoylecgonine
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Benzodiazepines, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Benzodiazepines, with Confirmation, Urine - The benzodiazepine class of drugs are traditionally classified as depressants. They are used therapeutically to produce sedation, induce sleep, relieve anxiety, treat muscle spasms, and to prevent seizures. In general, benzodiazepines act as hypnotics in high doses, anxiolytics in moderate doses, and sedatives in low doses. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the benzodiazepines is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d
.
Initial screen of the Benzodiazepines drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80346; HCPCS: G0480).
Confirmation includes the following analytes: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam

Reference Range(s)
Benzodiazepines    <100 ng/mL
  Alphahydroxyalprazolam    <25 ng/mL
  Alphahydroxymidazolam    <50 ng/mL
  Alphahydroxytriazolam    <50 ng/mL
  Aminoclonazepam    <25 ng/mL
  Hydroxyethylflurazepam    <50 ng/mL
  Lorazepam    <50 ng/mL
  Nordiazepam    <50 ng/mL
  Oxazepam    <50 ng/mL
  Temazepam    <50 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine

Clinical Significance
Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine - Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Buprenorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80348, 80362; HCPCS: G0480).
Confirmation includes the following analytes: Buprenorphine, Norbuprenorphine, Naloxone

Reference Range(s)
Buprenorphine    <5 ng/mL
  Buprenorphine    <2 ng/mL
  Norbuprenorphine    <2 ng/mL
  Naloxone    <2 ng/mL

Alternative Name(s)
Naloxone,Suboxone®,Pain Management,Prescription Drug Monitoring

Drug Monitoring, Cocaine Metabolite, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Cocaine Metabolite, with Confirmation, Urine - Cocaine is sometimes used clinically as a local anesthetic. More commonly however, it is used illicitly. Identification and verification of cocaine's metabolite benzoylecgonine in urine is most often used to show illicit use. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the cocaine is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Cocaine Metabolite drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80353; HCPCS: G0480)
Confirmation includes the following analytes: Benzoylecgonine

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Fentanyl, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Fentanyl, with Confirmation, Urine - Fentanyl is an opioid analgesic with a potency approximately 80 times that of morphine. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of fentanyl is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
If the presumptive (screen) is positive, a confirmation will be performed at an additional charge (CPT code(s): 80354).
Confirmation includes the following analytes: Fentanyl, Norfentanyl

Reference Range(s)
Fentanyl    <0.5 ng/mL
  Fentanyl    <0.5 ng/mL
  Norfentanyl    <0.5 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Heroin Metabolite, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Heroin Metabolite, with Confirmation, Urine - 6-Monoacetylmorphine is the primary metabolite of heroin. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of 6-Monoacetylmorphine is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the 6-Acetylmorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80356; G0480).
Confirmation includes the following analytes: 6-Acetylmorphine

Reference Range(s)
6-Acetylmorphine    <10 ng/mL
  6-Acetylmorphine    <10 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Marijuana Metabolite, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Marijuana Metabolite, with Confirmation, Urine - 11-Nor-9-Carboxy-delta 9 -THC (THCCOOH) is commonly accepted as the primary urinary metabolite in man. Detection of this metabolite is indicative of exposure to marijuana. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of THCCOOH is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Marijuana Metabolite drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80349; G0480).
Confirmation includes the following analytes: Marijuana Metabolite

Reference Range(s)
Marijuana Metabolite    <20 ng/mL
  Marijuana Metabolite    <5 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, MDMA/MDA, with Confirmation, Urine

Clinical Significance
Drug Monitoring, MDMA/MDA, with Confirmation, Urine - 3,4-Methylenedioxymethamphetamine (MDMA, aka Ecstasy, Molly) is a stimulant that is hallucinogenic in large does. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of MDMA is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the MDMA drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80359; MCR: G0480).
Confirmation includes the following analytes: MDA, MDMA

Reference Range(s)
MDMA    <500 ng/mL
  MDMA    <200 ng/mL
  MDA    <200 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Methadone Metabolite, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Methadone Metabolite, with Confirmation, Urine - Methadone is prescribed to patients for the alleviation of opioid addiction withdrawal symptoms and analgesic purposes. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of methadone and its metabolite EDDP is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Methadone Metabolite drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80358; HCPCS: G0480).
Confirmation includes the following analytes: EDDP, Methadone

Reference Range(s)
Methadone Metabolite    <100 ng/mL
  EDDP    <100 ng/mL
  Methadone    <100 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Mitragynine, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Mitragynine, with Confirmation, Urine - Monitoring of Mitragynine in urine, the results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
If screening drug class result is equal to or greater than the cutoff, then confirmation testing will be performed at an additional charge (CPT code(s): 80323)

Reference Range(s)
Mitragynine    <50 ng/mL
  Mitragynine Confirmation    <2 ng/mL

Alternative Name(s)
Kratom,Prescription Drug Monitoring,Pain Management

Drug Monitoring, Opiates, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Opiates, with Confirmation, Urine - Opiates possess exceptional analgesic properties and have become the mainstay of pain management therapies. Being both psychologically and physically addictive, the monitoring of opiate use and abuse is a major component of any treatment program. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of the opiates is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Opiates drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80361; G0480).
Confirmation includes the following analytes: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone

Reference Range(s)
Opiates    <100 ng/mL
  Codeine    <50 ng/mL
  Hydrodcodone    <50 ng/mL
  Hydromorphone    <50 ng/mL
  Morphine    <50 ng/mL
  Norhydrocodone    <50 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Oxycodone, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Oxycodone, with Confirmation, Urine - Oxycodone is a semisynthetic narcotic analgesic that is available in oral formulations, often in combination with other drugs such as acetaminophen, aspirin, phenacetin, and caffeine. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to amore specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of oxycodone and its metabolite oxymorphone is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes strategies as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Oxycodone drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80365; HCPCS: G0480).
Confirmation includes the following analytes: Noroxycodone, Oxycodone, Oxymorphone

Reference Range(s)
Oxycodone    <100 ng/mL
  Noroxycodone    <50 ng/mL
  Oxycodone    <50 ng/mL
  Oxymorphone    <50 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 1, with Confirmation, with D/L Isomers, Urine

Clinical Significance
Drug Monitoring, Panel 1, with Confirmation, with D/L Isomers, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Amphetamines: Amphetamine, Methamphetamine
If the Methamphetamine is reported positive (≥250 ng/mL), Pain Management, Methamphetamine, D/L Isomers, Urine will be performed at an additional charge (CPT code(s): 80374; HCPCS: G0480).
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone
Phencyclidine: Phencyclidine

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 3, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 3, with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Amphetamines, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Opiates, Oxycodone drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Amphetamines: Amphetamine, Methamphetamine
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 4, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 4, with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Amphetamines, Barbiturates, Benzodiazepines, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone, Phencyclidine drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Amphetamines: Amphetamine, Methamphetamine
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone
Phencyclidine: Phencyclidine

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 5, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 5, with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone, Opiates, Oxycodone drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Amphetamines: Amphetamine, Methamphetamine
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 5, with Confirmation, with D/L Isomers, Urine

Clinical Significance
Drug Monitoring, Panel 5, with Confirmation, with D/L Isomers, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
Amphetamines: Amphetamine, Methamphetamine
If the Methamphetamine is reported positive (≥250 ng/mL), Pain Management, Methamphetamine, D/L Isomers, Urine will be performed at an additional charge (CPT code(s): 80374; HCPCS: G0480).
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 7 with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 7 with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of 6-Acetylmorphine, Alcohol Metabolites, Amphetamines, Barbiturates, Benzodiazepines, Marijuana Metabolite, Cocaine Metabolite, Methadone Metabolite, Opiates, Oxycodone drug classes. Specimen validity consisting of Creatinine, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
6-Acetylmorphine: 6-Acetylmorphine
Alcohol Metabolites: Ethyl Glucuronide (ETG), Ethyl Sulfate (ETS)
Amphetamines: Amphetamine, Methamphetamine
Barbiturates: Amobarbital, Butalbital, Pentobarbital, Phenobarbital, Secobarbital
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
Methadone Metabolite: EDDP, Methadone
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Panel 8 with Confirmation, Urine

Clinical Significance
Drug Monitoring, Panel 8 with Confirmation, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screen results are reflexed to a more specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) test. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of 6-Acetylmorphine, Alcohol Metabolites, Amphetamines, Benzodiazepines, Buprenorphine, Marijuana Metabolite, Cocaine Metabolite, MDMA, Opiates, Oxycodone drug classes. Specimen validity consisting of Creatinine, Specific Gravity, Oxidant, and pH testing.
If screen of drug class is positive, a confirmation of the drug class will be performed at an additional charge (CPT code(s): dependent upon the confirmed drug class).
Confirmation includes the following analytes within their associated drug class:
6-Acetylmorphine: 6-Acetylmorphine
Alcohol Metabolites: Ethyl Glucuronide (ETG), Ethyl Sulfate (ETS)
Amphetamines: Amphetamine, Methamphetamine
Benzodiazepines: Alphahydroxyalprazolam, Alphahydroxymidazolam, Alphahydroxytriazolam, Aminoclonazepam, Hydroxyethylflurazepam, Lorazepam, Nordiazepam, Oxazepam, Temazepam
Buprenorphine: Buprenorphine, Norbuprenorphine
Marijuana Metabolite: Marijuana Metabolite
Cocaine Metabolite: Benzoylecgonine
MDMA: MDA, MDMA
Opiates: Codeine, Hydrocodone, Hydromorphone, Morphine, Norhydrocodone
Oxycodone: Noroxycodone, Oxycodone, Oxymorphone

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Drug Monitoring, Phencyclidine, with Confirmation, Urine

Clinical Significance
Drug Monitoring, Phencyclidine, with Confirmation, Urine - Phencyclidine (PCP, "angel dust") is an illicit psychotropic drug that causes anxiety, disorientation, and acute confusion resembling schizophrenia. The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Presumptive positive screening tests are reflexed to amore specific and sensitive liquid chromatography mass spectroscopy (LC/MS/MS) confirmation test. Therapeutic urine drug monitoring of PCP is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Phencyclidine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 83992; HCPCS: G0480).
Confirmation includes the following analytes: Phencyclidine

Reference Range(s)
Phencyclidine    <25 ng/mL
  Phencyclidine    <25 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management